Generates the richest clinical evidence
Clario (bioclinica.com) earns a Brand Analyzer score of 78 out of 100, placing it in the Brand-Ready tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, Clario ranks in the 94th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 100/100, Digital Presence 76/100, Visual Identity 90/100, Messaging Clarity 95/100, Trust Foundation 67/100, AI Discoverability 78/100, Brand Authority 61/100.
Clario is a clinical trial endpoint technology company founded in 2019 and headquartered in London. A part of Thermo Fisher Scientific, Clario combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence across all trial phases. It focuses on cardiac safety and efficacy endpoint solutions, serving pharmaceutical companies and researchers conducting drug trials worldwide with the goal of elevating efficacy, ensuring safety, and improving patient quality of life.
| Brand Name | Clario |
|---|---|
| Domain | bioclinica.com |
| Industry | Healthcare, SaaS |
| Founded | 2019 |
| Headquarters | London |
| Parent Company / Owner | Thermo Fisher Scientific |
| Main Competitors | Medidata Solutions, ICON plc (84/100), Covance, ERT (eResearchTechnology), BioClinica (78/100), Veeva Systems (81/100) |
Moz Domain Authority 47/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #387,365 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Clario has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "Clario, a part of Thermo Fisher Scientific, combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence for every trial …" (Meta description: 25 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on LinkedIn, Facebook, Instagram; no detected presence on X (Twitter), YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Clario scores 60/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Clario has a moderate AI-visibility profile at 60/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is visibility (68/100) and its weakest is recommendation likelihood (49/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #387,365 (Tranco). The main gaps holding it back: no llms.txt to steer AI to its best pages.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Clario's main competitors include Medidata Solutions, ICON plc, Covance, ERT (eResearchTechnology), BioClinica (78/100). These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Clario official site
Clario and Veeva Systems are competitors in Healthcare. Brand Analyzer scores Clario at 78/100 and Veeva Systems at 81/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Clario official site
Popular alternatives to Clario include Medidata Solutions, ICON plc, Covance, ERT (eResearchTechnology), BioClinica (78/100). Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Clario official site
Clario is a clinical trial endpoint technology company headquartered in London, founded in 2019. It operates as part of Thermo Fisher Scientific. Clario is positioned as a leading provider of science-informed endpoint technology and expert services designed to generate reliable clinical evidence for every phase of a clinical trial, with a particular focus on cardiac safety and efficacy endpoints.
Sources: Clario official site
Clario has moderate AI-search visibility, scoring 60/100 on Brand Analyzer's AI visibility composite (visibility 68, trust 56, recommendation 49). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Clario official site
Clario was founded in 2019. Clario operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Clario is headquartered in London. Clario operates in the Healthcare category.
Sources: Wikidata
Clario combines science-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence across all phases of clinical drug trials. It provides cardiac safety and efficacy endpoint solutions for pharmaceutical companies and researchers worldwide. As part of Thermo Fisher Scientific, Clario works to elevate efficacy, ensure safety, and improve patient quality of life throughout the drug development process.
Sources: Clario official site
Clario offers endpoint technology solutions and expert services for clinical drug trials. Its offerings specifically include cardiac safety and efficacy endpoint solutions applicable to all phases of drug trials worldwide. These services are delivered with global scale and are designed to generate reliable clinical evidence, elevate efficacy, ensure patient safety, and improve patient quality of life. More granular product names or details are not specified in the available facts.
Sources: Clario official site
Clario scores 49/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Clario official site
Clario's primary users are pharmaceutical companies and researchers conducting clinical drug trials. Its solutions are designed to support these organizations across all phases of drug development, from early-phase trials to late-stage studies. Given its global scale, it serves clients worldwide seeking science-informed endpoint technology and expert services to generate reliable clinical evidence.
Sources: Clario official site
Clario is known for providing science-informed endpoint technology and expert services for clinical trials. It is particularly recognized for its cardiac safety and efficacy endpoint solutions that span all phases of drug trials worldwide. Its association with Thermo Fisher Scientific and its global scale further distinguish it as a leading provider in the clinical trial endpoint technology space.
Sources: Clario official site
Clario can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Clario official site
Ranked closest to Clario: Binti (78/100), Amedisys (78/100), Biogen (78/100), Bluefin (78/100).
A step up - brands to learn from: Zipline (81/100), Zimmer Biomet (81/100).
Category leader: Dassault Systèmes (95/100).